Search results
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s...
Digital Journal· 5 days ago...Published June 20, 2024 ACCESSWIRE PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo...
Here's Why Novartis (NVS) is a Strong Momentum Stock
Zacks via Yahoo Finance· 5 days agoEmploying factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 4 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 5 days agoSome popular names in the pharma sector are Pfizer PFE, Johnson & Johnson JNJ, Novo Nordisk NVO,...
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Finance· 5 days agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...
Swiss Dividend Stocks To Watch In June 2024
Simply Wall St. via Yahoo Finance· 23 hours agoAmid a backdrop of a declining Switzerland market, with the SMI index closing down by 0.95% amid global economic growth concerns, investors may be...
Foreign banks target Switzerland after UBS takeover of Credit Suisse
Reuters via Yahoo Finance· 16 hours agoAs Credit Suisse fades into history following its takeover by UBS last year, global banks are...
Does Legend Biotech (LEGN) Have a Long Runway for Growth?
Insider Monkey via Yahoo Finance· 15 hours agoTimesSquare Capital Management, an equity investment management company, released its “U.S. Focus...
Here's Why Novartis (NVS) is a Strong Momentum Stock
Zacks· 5 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Experts Advise on Early-Risk Monitoring for Type 1 Diabetes
Medscape· 22 hours agoA new international consensus statement offers guidance for primary care and endocrinology providers...